nitroxoline has been researched along with Urinary Bladder Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, S; Ding, L; Huang, P; Jiang, M; Li, G; Lu, Z; Luo, W; Ren, L; Wang, H; Wang, M; Wang, R; Xia, L; Xie, H; Xu, L; Xu, N; Xue, D; Yu, H; Yu, S | 1 |
| Araki, M; Huang, P; Lin, W; Liu, C; Nasu, Y; Sadahira, T; Sun, J; Wada, K; Watanabe, M; Xu, A; Xu, N | 1 |
| Bhang, HE; Bhat, S; Chong, CR; Dhara, S; Han, KC; Liu, JO; Matsui, Y; Nacev, BA; Pomper, MG; Shim, JS; So, A; Xu, J | 1 |
3 other study(ies) available for nitroxoline and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Early Growth Response Protein 1; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Nitroquinolines; RNA, Circular; Signal Transduction; Smad7 Protein; Transcription Factors; Urinary Bladder Neoplasms | 2022 |
Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer.
Topics: Animals; Anti-Infective Agents, Urinary; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carcinoma, Transitional Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nitroquinolines; Signal Transduction; STAT3 Transcription Factor; Urinary Bladder Neoplasms | 2021 |
Effect of nitroxoline on angiogenesis and growth of human bladder cancer.
Topics: Acetylation; Aminopeptidases; Angiogenesis Inhibitors; Animals; Anti-Infective Agents, Urinary; Breast Neoplasms; Cell Proliferation; Collagen; Cyclohexanes; Disease Models, Animal; Drug Combinations; Drug Synergism; Endothelial Cells; Endothelium, Vascular; Female; Glycoproteins; Humans; Immunoblotting; Immunohistochemistry; Laminin; Methionyl Aminopeptidases; Mice; Mice, Nude; Neovascularization, Pathologic; Nitroquinolines; O-(Chloroacetylcarbamoyl)fumagillol; Proteoglycans; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Sesquiterpenes; Sirtuin 1; Transfection; Umbilical Veins; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2010 |